The story has been updated to include comments from NeoGenomics' conference call on Wednesday.

NEW YORK (GenomeWeb) – NeoGenomics on Wednesday said that its fourth quarter revenues more than doubled year over year as clinical genetic test volumes also shot up, driven by the inclusion of Clarient's results.

NeoGenomics acquired Clarient from GE Healthcare Life Sciences at the end of 2015.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Customers might want to consider what they might learn about their risk of diseases like Alzheimer's before snagging the genetic testing kits that are on many gift guides this year, NJ.com writes.

The Wall Street Journal reports there is uncertainty surrounding whether He Jiankui's embryo editing did what he said it did.

Stat News reports that the pause on procuring fetal tissue for intramural US National Institutes of Health research will soon affect additional labs there.

In Nature this week: genomic analysis of the invasive fall webworm, amp of constrained coding regions within the human genome, and more.